Shanghai Team Analyzes Mechanism That Enables Adult Cells To Behave Like Embryonic Stem Cells
Main Category: Stem Cell ResearchArticle Date: 08 Mar 2009 - 0:00 PDT
| Patient / Public: | ![]() |
3.5 (2 votes) |
| Healthcare Prof: | ![]() |
Agilent Technologies Inc. (NYSE:A) today announced its collaboration with a team from the Shanghai Institutes for Biological Sciences and Tongi University that has achieved new insight into how adult cells can be induced to act like embryonic stem cells (ESC), with the ability to form any type of tissue known as "pluripotency."
"The value of finding alternatives to embryonic stem cells would obviously be tremendous, and the ability to induce pluripotency in adult cells, discovered in 2006, is considered a breakthrough," said Jian Li of Agilent Technologies Shanghai, one of the article's coauthors. "Now we're gaining new understanding into how this pluripotency was actually induced."
Their findings were published in the journal"Cell Research," in an article titled "Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells" (Cell Research, 2008 18:1177-1189). The researchers observed a developmental signaling network of 16 signaling pathways, including nine that had not previously been assigned roles in maintaining or inducing pluripotency.
The study used Agilent chromatin immunoprecipitation-on-chip (ChIP-on-chip) and gene expression microarrays to study molecules known as "Yamanaka factors" and their roles in inducing pluripotency in mouse cells.
Agilent provided the microarray kits for this research under an Agilent grant issued in 2008. Microarrays are glass wafers containing large numbers of DNA probes used to analyze genomic activity. ChIP-on-chip microarrays are used to observe activity at "promoter regions" on the genome, where chemical events activate and deactivate various genes to control cellular functioning.
About Agilent Technologies
Agilent Technologies Inc. (NYSE:A) is the world's premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company's 19,000 employees serve customers in more than 110 countries. Agilent had net revenues of $5.8 billion in fiscal 2008. Information about Agilent is available on the Web at http://www.agilent.com.
Agilent Technologies
Visit our stem cell research section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/141432.php>
APA
http://www.medicalnewstoday.com/releases/141432.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





